IDH2 and myelodysplastic syndrome: Thus, Patnaik et al. have explored a group of 277 MDS patients and reported IDH mutations in 12% of these patients: About 9.4% displayed IDH2 mutations (all R140Q) and 2.6% IDH1 mutations (mostly R132S) [22].